PT  - JOURNAL ARTICLE
AU  - Hoyle, Brian
ED  - Kereiakes, Dean J.
TI  - SYNERGY Everolimus-Eluting Stent Noninferior to PROMUS Element Plus: Results from EVOLVE II Randomized Clinical Trial
DP  - 2014  01
TA  - MD Conference Express
PG  - 21--22
VI  - 14
IP  - 52
4099  - http://mdc.sagepub.com/content/14/52/21.short
4100  - http://mdc.sagepub.com/content/14/52/21.full
AB  - This article reports on the primary outcomes of the prospective, randomized, single-blind, multicenter EVOLVE II Clinical Trial to Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s) [EVOLVE II; NCT01665053], which assessed the safety and effectiveness of 2 different everolimus-eluting stents, the second-generation SYNERGY stent and the PROMUS Element Plus durable-polymer drug-eluting stent.